(CON) Concentra Holdings Parent - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US20603L1026

CON EPS (Earnings per Share)

This chart shows the EPS (Earnings per Share) of CON over the last 5 years for every Quarter.

CON Revenue

This chart shows the Revenue of CON over the last 5 years for every Quarter.

CON: Occupational, Health, Services, Primary, Care, Preventive, Wellness

Concentra Group Holdings Parent, Inc. (NYSE: CON) is a leading provider of occupational health services in the United States, operating an extensive network of over 500 clinics nationwide. The company offers a comprehensive suite of services tailored to employers and workers, including injury care, primary care, urgent care, preventive care, and wellness programs. Concentras services are designed to address workplace health challenges, with a focus on preventive care, clinical testing, physical examinations, drug and alcohol screenings, and vaccinations. The company also provides telemedicine solutions through Concentra Telemed, enabling remote treatment of work-related injuries and illnesses. Additionally, Concentra offers pharmacy solutions and compliance administration services to manage workplace drug testing programs efficiently.

Founded in 1979 and headquartered in Mechanicsburg, Pennsylvania, Concentra Group Holdings Parent, Inc. is a subsidiary of Select Medical Corporation. The companys approach combines clinical expertise with a focus on reducing workplace hazards and promoting employee well-being. Concentras services are complemented by a range of consultative programs aimed at enhancing workplace safety and health outcomes. With a strong emphasis on employer-sponsored health services, Concentra has established itself as a key player in the occupational health sector, catering to both regulated and non-regulated industries.

### 3-Month Forecast Based on the provided and , here is a concise 3-month forecast for Concentra Group Holdings Parent, Inc. (NYSE: CON): - Technical Outlook: The stocks SMA20 (20.93) is slightly below the last price (21.61), indicating a bullish trend. The ATR (0.76) suggests moderate volatility, which may stabilize given the SMA200 (21.63) aligning closely with the current price. - Fundamental Outlook: With a market cap of $2.926B and a P/S ratio of 1.57, the stock is moderately valued. The forward P/E of 18.05 indicates potential for growth, supported by the companys strong position in the occupational health services market. This forecast suggests that Concentra is likely to maintain its stable performance, with potential for moderate growth driven by its comprehensive service offerings and market position.

Additional Sources for CON Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

CON Stock Overview

Market Cap in USD 2,767m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Services
IPO / Inception 2024-07-25

CON Stock Ratings

Growth Rating -15.0
Fundamental 31.9
Dividend Rating 33.6
Rel. Strength 7.82
Analysts 4.63 of 5
Fair Price Momentum 20.24 USD
Fair Price DCF 29.95 USD

CON Dividends

Dividend Yield 12m 0.88%
Yield on Cost 5y 0.85%
Annual Growth 5y 41.42%
Payout Consistency 100.0%
Payout Ratio 13.9%

CON Growth Ratios

Growth Correlation 3m 15.2%
Growth Correlation 12m -19.3%
Growth Correlation 5y -19.3%
CAGR 5y -2.93%
CAGR/Max DD 5y -0.14
Sharpe Ratio 12m -0.64
Alpha -9.90
Beta 0.277
Volatility 34.68%
Current Volume 471.3k
Average Volume 20d 471.1k
What is the price of CON shares?
As of June 01, 2025, the stock is trading at USD 21.63 with a total of 471,286 shares traded.
Over the past week, the price has changed by +2.32%, over one month by -1.23%, over three months by -4.21% and over the past year by -2.93%.
Is Concentra Holdings Parent a good stock to buy?
Neither. Based on ValueRay´s Fundamental Analyses, Concentra Holdings Parent is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 31.86 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CON is around 20.24 USD . This means that CON is currently overvalued and has a potential downside of -6.43%.
Is CON a buy, sell or hold?
Concentra Holdings Parent has received a consensus analysts rating of 4.63. Therefor, it is recommend to buy CON.
  • Strong Buy: 5
  • Buy: 3
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecasts for CON share price target?
According to our own proprietary Forecast Model, CON Concentra Holdings Parent will be worth about 21.9 in June 2026. The stock is currently trading at 21.63. This means that the stock has a potential upside of +1.06%.
Issuer Target Up/Down from current
Wallstreet Target Price 28 29.4%
Analysts Target Price 28 29.4%
ValueRay Target Price 21.9 1.1%